Inhibition of serine β-lactamases by vanadate-catechol complexes

Biochemistry

Volumn 47, Issue 36, 2008, Pages 9467-9474

  Adediran, S A ^a   Pratt, R F ^a  

^a WESLEYAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS;

AQUEOUS BUFFERS; LACTAMASES; MICROMOLAR LEVELS; NEUTRAL PH;

VANADIUM COMPOUNDS;

BETA LACTAMASE INHIBITOR; VANADIC ACID; VANADIUM;

ARTICLE; CATALYST; CHEMICAL STRUCTURE; DRUG INHIBITION; ENZYME ACTIVITY; HYDROPHOBICITY; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL;

BACTERIAL PROTEINS; BETA-LACTAMASES; CATECHOLS; ENTEROBACTER CLOACAE; ENZYME INHIBITORS; HYDROPHOBICITY; MODELS, MOLECULAR; OXIDATION-REDUCTION; VANADATES;

EID: 51549098187     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi801153j     Document Type: Article

References (53)

1. Projan, S. J., and Bradford, P. A. (2007) Late stage antibacterial drugs in the clinical pipeline. Curr. Opin. Microbiol. 10, 441-446.
2. Payne, D. J., Gwynn, M. N., Holmes, D. J., and Pompliano, D. L. (2007) Drugs for bad bugs: Confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discovery 6, 29-40.
3. Fisher, J. F., Meroueh, S. O., and Mobashery, S. (2005) Bacterial resistance to β-lactam antibiotics: Compelling opportunism, compelling opportunity. Chem. Rev. 105, 395-424.
4. Buynak, J. D. (2006) Understanding the longevity of the β-lactam antibiotics and of antibiotic/β-lactamase inhibitor combinations. Biochem. Pharmacol. 71, 930-940.
5. Georgopapadakou, N. (2004) β-Lactamase inhibitors: Evolving compounds for evolving resistance targets. Expert Opin. Invest. Drugs 13, 1307-1318.
6. Silver, L. L. (2007) Novel broad spectrum β-lactamase inhibitors. Expert Opin. Ther. Pat. 17, 1175-1181.
7. Crompton, I. E., Cuthbert, B. K., Lowe, G., and Waley, S. G. (1988) β-Lactamase inhibitors. The inhibition of serine β-lactamases by specific boronic acids. Biochem. J. 251, 453-459.
8. Martin, R., and Jones, J. B. (1995) Rational design and synthesis of a highly effective transition state analog inhibitor of the RTEM-1 β-lactamase. Tetrahedron Lett. 46, 8399-8402.
9. Weston, G. S., Blazquez, J., Baquero, F., and Shoichet, B. K. (1998) Structure-based enhancement of boronic acid-based inhibitors of Amp C β-lactamase. J. Med. Chem. 41, 4577-4586.
10. Morandi, F., Caselli, E., Morandi, S., Focia, P. J., Blazquez, J., Shoichet, B. K., and Prati, F. (2003) Nanomolar inhibitors of Amp C β-lactamase. J. Am. Chem. Soc. 125, 685-695.
11. Pratt, R. F. (1989) Inhibition of a class C β-lactamase by a specific phosphonate monoester. Science 246, 917-919.
12. Rahil, J., and Pratt, R. F. (1992) Mechanism of inhibition of the class C β-lactamase of Enterobacter cloacae P99 by phosphonate monoesters. Biochemistry 31, 5869-5878.
13. Chen, C. C. H., Rahil, J., Pratt, R. F., and Herzberg, O. (1993) Structure of a phosphonate-inhibited β-lactamase. An analog of the tetrahedral transition state/intermediate of β-lactam hydrolysis. J. Mol. Biol. 234, 165-178.
14. Lobkovsky, E., Billings, E. M., Moews, P. C., Rahil, J., Pratt, R. F., and Knox, J. R. (1994) Crystallographic structure of a phosphonate derivative of the Enterobacter cloacae P99 cephalosporinase: Mechanistic interpretation of a β-lactamase transition state analog. Biochemistry 33, 6762-6772.
15. Ness, S., Martin, R., Kindler, A. M., Paetzel, M., Gold, M., and Jones, J. B. (2000) Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 β-lactamase. Biochemistry 39, 5312-5321.
16. Powers, R. A., Caselli, E., Focia, P. J., Prati, F., and Shoichet, B. K. (2001) Structures of ceftazidime and its transition state analogue in complex with Amp C β-lactamase: Implications for resistance mutations and inhibitor design. Biochemistry 40, 9207-9214.
17. Bell, J. H., and Pratt, R. F. (2002) Mechanism of inhibition of the β-lactamase of Enterobacter cloacae P99 by 1:1 complexes of vanadate with hydroxamic acids. Biochemistry 41, 4329-4338.
18. Kustin, K., and Toppen, D. L. (1973) Kinetics of complexation of vanadate ions by ethylenediaminetetraacetic acid and 1,2-dihy-droxyanthraquinone. J. Am. Chem. Soc. 95, 3564-3568.
19. Kustin, K., Liu, S.-T., Nicolini, C., and Toppen, D. L. (1974) Interaction of catechol and catechol derivatives with dioxovanadium (V). I. Kinetics of complex formation in acidic media. J. Am. Chem. Soc. 96, 7410-7415.
20. Cass, M. E., Gordon, N. R., and Pierpont, C. G. (1986) Catecholate and semiquinone complexes of vanadium. Factors that direct charge distribution in metal-quinone complexes. Inorg. Chem. 25, 3962-3967.
21. V-imidazole complexes. Inorg. Chem. 31, 1981-1983.
22. Cornman, C. R., Colpas, G. R., Hoeschele, J. D., Kampf, J., and Pecoraro, V. L. (1992) Implications for the spectroscopic assignment of vanadium biomolecules: Structural and spectroscopic characterization of monooxovanadium(V) complexes containing catecholate and hydroximate based noninnocent ligands. J. Am. Chem. Soc. 114, 9925-9933.
23. Bharat, B., Das, S., and Chakravorty, A. (2002) A family of vanadate esters of monoionized and diionized aromatic 1,2,- diols: Synthesis, structure and redox activity. Inorg. Chem. 41, 4502-4508.
24. Yin, C.-X., and Finke, R. E. (2005) Vanadium-based, extended catalytic lifetime catechol dioxygenases: Evidence for a common catalyst. J. Am. Chem. Soc. 127, 9003-9013.
25. Joris, B., De Meester, F., Galleni, M., Reckinger, G., Coyette, J., Frere, J.-M., and van Beeumen, J. (1985) The β-lactamase of Enterobacter cloacae P99. Chemical properties, N-terminal sequence and interaction with 6β-halogenopenicillanates. Biochem. J. 228, 241-248.
26. Fisher, J., Belasco, J. G., Khosla, S., and Knowles, J. R. (1980) β-Lactamase proceeds via an acyl-enzyme intermediate. Interaction of the Escherichia coli RTEM enzyme with cefoxitin. Biochemistry 19, 2895-2900.
27. Weygand, F. (1943) Eine neue isonaphthazarin-synthese. Ber. 75 B, 625-626.
28. Bebrone, C., Moali, C., Mahy, F., Rival, S., Docquier, J. D., Rossolini, G. M., Fastrez, J., Pratt, R. F., Frère, J.-M., and Galleni, M. (2001) CENTA as a chromogenic substrate for studying β-lactamases. Antimicrob. Agents Chemother. 45, 1868-1871.
29. Golemi, D., Maveyraud, L., Vakulenko, S., Samama, J.-P., and Mobashery, S. (2001) Critical involvement of a carbamylated lysine in catalytic function of class D β-lactamases. Proc. Natl. Acad. Sci. U.S.A. 98, 14280-14285.
30. Kuzmic, P. (1996) Program DYNAFIT for the analysis of enzyme kinetic data: Application to HIV proteinase. Anal. Biochem. 237, 260-273.
31. Stankiewicz, P. J., Gresser, M. J., Tracey, A. S., and Hass, L. F. (1987) 2,3-Diphospho-glycerate phosphatase activity of phosphoglycerate mutase: Stimulation by vanadate and phosphate. Biochemistry 26, 1264-1269.
32. Curley, K., and Pratt, R. F. (1997) Effectiveness of tetrahedral adducts as transition state analogs and inhibitors of the class C β-lactamase of Enterobacter cloacae P99. J. Am. Chem. Soc. 119, 1529-1538.
33. Krauss, M., and Basch, H. (1992) Is the vanadate anion an analogue of the transition state of RNAse A? J. Am. Chem. Soc. 114, 3630-3634.
34. Manos, M. J., Tasiopolis, A. J., Raptopolou, C., Terzis, A., Woollins, J. D., Slawin, A. M. Z., Keramidas, A. D., and Kabanos, T. A. (2001) Unexpected reduction of vanadium(IV) to vanadium(III) in the presence of the chelate ligands 2,2′-bipyridine (bpy) and 1,8-hydroxyquinoline (Hquin). J. Chem. Soc., Dalton Trans., 1556-1558.
35. Page, M. I., Vilanova, B., and Layland, N. J. (1995) pH dependence of and kinetic solvent isotope effects on the methanolysis and hydrolysis of β-lactams catalyzed by class C β-lactamase. J. Am. Chem. Soc. 117, 12092-12095.
36. Gresser, M. J., and Tracey, A. S. (1985) Vanadium(V) oxyanions: The esterification of ethanol with vanadate. J. Am. Chem. Soc. 107, 4215-4220.
37. Tondi, D., Powers, R. A., Caselli, E., Negri, M.-C., Blázquez, J., Costi, M. P., and Shoichet, B. K. (2001) Structure-based design and in-parallel synthesis of inhibitors of AmpC β-lactamase. Chem. Biol. 8, 593-610.
38. Kaur, K., and Pratt, R. F. (2001) Mechanism of reaction of acyl phosph(on)ates with the β-lactamase of Enterobacter cloacae P99. Biochemistry 40, 4610-4621.
39. Monaghan, C., Holland, S., and Dale, J. W. (1982) The interaction of anthraquinone dyes with the plasmid-mediated OXA-2 β-lactamase. Biochem. J. 205, 413-417.
40. Majumdar, S., Adediran, S. A., Nukaga, M., and Pratt, R. F. (2005) Inhibition of class D β-lactamases by diaroyl phosphates. Biochemistry 44, 16121-16129.
41. Kustin, K., Nicolini, C., and Toppen, D. L. (1974) Interaction of catechol and catechol derivatives with dioxovanadium(V). II. Kinetics of ligand oxidation. J. Am. Chem. Soc. 96, 7416-7420.
42. Cantley, L. C., Jr., Ferguson, J. H., and Kustin, K. (1978) Norepinephrine complexes and reduced vanadium(V) to reverse vanadate inhibition of the (Na,K)-ATPase. J. Am. Chem. Soc. 100, 5210-5212.
43. Ferguson, J. H., and Kustin, K. (1979) Interactions between vanadate and 1,2-aromatic diols. Complex formation and oxidation-reduction. Inorg. Chem. 18, 3349-3357.
44. Süss-Fink, G., Cuervo, L. G., Therrien, B., Stoeckli-Evans, H., and Shul'pin, G. B. (2004) Mono and oligonuclear vanadium complexes as catalysts for alkane oxidation: Synthesis, molecular structure, and catalytic potential. Inorg. Chim. Acta 357, 475-484.
45. Bell, J. H., and Pratt, R. F. (2002) Formation and structure of 1:1 complexes between aryl hydroxamic acids and vanadate at neutral pH. Inorg. Chem. 41, 2747-2753.
46. Moulin, A., Bell, J. H., Pratt, R. F., and Ringe, D. (2007) Inhibition of chymotrypsin by a complex of ortho-vanadate and benzohydroxamic acid: Structure of the inert complex and its mechanistic interpretation. Biochemistry 46, 5982-5990.
47. Ness, S., Martin, R., Kindler, A. M., Paetzel, M., Gold, M., Jensen, S. E., Jones, J. B., and Strynadka, N. C. J. (2000) Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 β-lactamase. Biochemistry 39, 5312-5321.
48. Usher, K. C., Blaszczak, L. C., Weston, G. S., Shoichet, B. K., and Remington, S. J. (1998) Three-dimensional structure of AmpC β-lactamase from Escherichia coli bound to a transition-state analogue: Possible implications for the oxyanion hypothesis and for inhibitor design. Biochemistry 37, 16082-16092.
49. Crans, D. C., Smee, J. J., Gaidamauskas, E., and Yang, L. (2004) The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. Chem. Rev. 104, 849-902.
50. Pizer, R., and Babcock, L. (1977) Mechanism of complexation of boron acids with catechol and substituted catechols. Inorg. Chem. 16, 1677-1681.
51. Babcock, L., and Pizer, R. (1980) Dynamics of boron acid complexation reactions. Formation of 1:1 boron acid-ligand complexes. Inorg. Chem. 19, 56-61.
52. Pasdeloup, M., and Brisson, C. (1981) NMR study of the complexation of boric acid with catechol (1,2-dihydroxybenzene). Org. Magn. Reson. 16, 164-167.
53. Adediran, S. A., Nukaga, M., Baurin, S., Frère, J. M., and Pratt, R. F. (2005) Inhibition of class D β-lactamases by acyl phosphates and phosphonates. Antimicrob. Agents Chemother. 49, 4410-4412.